Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

Xiaochen Wang , Lijun Liu

Global Medical Genetics ›› 2024, Vol. 11 ›› Issue (03) : 225 -226.

PDF (127KB)
Global Medical Genetics ›› 2024, Vol. 11 ›› Issue (03) : 225 -226. DOI: 10.1055/s-0044-1788572
Letter to the Editor
research-article

Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

Author information +
History +
PDF (127KB)

Cite this article

Download citation ▾
Xiaochen Wang, Lijun Liu. Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences. Global Medical Genetics, 2024, 11(03): 225-226 DOI:10.1055/s-0044-1788572

登录浏览全文

4963

注册一个新账户 忘记密码

Funding

None.

Conflict of Interest

None declared.

References

Publishing order | Descend order by publishing year | Descend order by cited within
[1]

Sun M, Yin Q, Liang Y, et al. Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study. Blood Sci 2024; 6(03) e00196
[2]

An G, Ge Z, Jing H, et al. Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010). Blood Sci 2024; 6(03) e00193
[3]

Chen Y, Xu Y, Li H, et al. A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia. N Engl J Med 2024; 390(23) 2178-2190

RIGHTS & PERMISSIONS

Global Medical Genetics

AI Summary AI Mindmap
PDF (127KB)

355

Accesses

0

Citation

Detail
Sections
Recommended

AI思维导图

/

〈 〉